Inotek Pharmaceuticals Corp. (delisted) (ITEK) News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Quarterly Report (10-q)

0001103795 false --12-31 2023 Q1...

Annual Report (10-k)

0001103795 false 2022 FY...

Quarterly Report (10-q)

0001103795 false --12-31 2022 Q3

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Quarterly Report (10-q)

0001103795 false 12/31 2022 Q1...

Annual Report (10-k)

0001103795 false FY 2021 --12-31 355000...

Current Report Filing (8-k)

0001103795 false 0001103795 2021-12-09 2021-12-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED...

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549   FORM 12b-25 NOTIFICATION OF...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Initial Statement of Beneficial Ownership (3)

FORM 3          UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...